依伐卡托(商品名Kalydeco)是一种用于治疗在囊性纤维化跨膜传导调节特定基因突变的人囊性纤维化的药物（CFTR）基因（主要是G551D突变），占4–5例囊性纤维化。它也包含在一个组合的药物，lumacaftor / ivacaftor（商品名orkambi），这是用来治疗囊性纤维化病患者谁在CFTR有F508del突变。
2,4-Di-tert-butyl-5-nitrophenol
4-Oxo-1,4-dihydroquinoline-3-carboxylic acid
2,4-Di-tert-butylphenyl methyl carbonate
Diethyl 2-(ethoxymethylene)malonate
Ethyl 3-(2-nitrophenyl)-3-oxopropanoate
5-Amino-2,4-di-tert-butylphenol
2,4-Di-tert-butylphenol
Methyl 3-methoxyacrylate
5-Amino-2,4-di-tert-butylphenyl methyl carbonate
Ethyl 4-oxo-1,4-dihydroquinoline-3-carboxylate
Diethyl 2-((phenylamino)methylene)malonate
N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
Methyl 2-aminobenzoate
2,4-Di-tert-butyl-5-(4-oxo-1,4-dihydroquinoline-3-carboxamido)phenyl methyl carbonate
2,4-Di-tert-butyl-5-nitrophenyl methyl carbonate
